Umeclidinium and vilanterol (Inhalation)

Medically reviewed by Drugs.com. Last updated on Mar 3, 2022.

Commonly used brand name(s)

In the U.S.

• Anoro Ellipta

Available Dosage Forms:

• Powder

Therapeutic Class: Respiratory Agent

Pharmacologic Class: Umeclidinium

Uses for umeclidinium and vilanterol

Umeclidinium and vilanterol combination is used as maintenance treatment of air flow blockage in patients with chronic obstructive pulmonary disease (COPD). COPD is a long-term lung disease that causes bronchospasm (wheezing or difficulty with breathing).

Umeclidinium and vilanterol combination should not be used for acute breathing problems or in patients with asthma.

Inhaled umeclidinium is an anticholinergic. Inhaled vilanterol is a long-acting bronchodilator. Bronchodilators are medicines that are breathed in through the mouth to open up the bronchial tubes (air passages) in the lungs.

Umeclidinium and vilanterol is available only with your doctor's prescription.

Before using umeclidinium and vilanterol

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For umeclidinium and vilanterol, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to umeclidinium and vilanterol or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Umeclidinium and vilanterol combination is not for use in the pediatric population. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of umeclidinium and vilanterol combination in the elderly. However, elderly patients are more sensitive to the effects of umeclidinium and vilanterol than younger adults.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking umeclidinium and vilanterol, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using umeclidinium and vilanterol with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.

• Bepridil
• Cisapride
• Dronedarone
• Fluconazole
• Ketoconazole
• Levoketoconazole
• Mesoridazine
• Nelfinavir
• Pimozide
• Piperaquine
• Posaconazole
• Pot...